We evaluated the value of resting-state EEG source biomarkers to characterize mild cognitive impairment (MCI) subjects with an Alzheimer's disease (AD)-like cerebrospinal fluid (CSF) profile and to track neurodegeneration throughout the AD continuum. We further applied a resting-state functional MRI (fMRI)-driven model of source reconstruction and tested its advantage in terms of AD diagnostic accuracy.
Resting-state electroencephalographic biomarkers of Alzheimer's disease / Cecchetti, Giordano; Agosta, Federica; Basaia, Silvia; Cividini, Camilla; Cursi, Marco; Santangelo, Roberto; Caso, Francesca; Minicucci, Fabio; Magnani, Giuseppe; Filippi, Massimo. - In: NEUROIMAGE. CLINICAL. - ISSN 2213-1582. - 31:(2021). [10.1016/j.nicl.2021.102711]
Resting-state electroencephalographic biomarkers of Alzheimer's disease
Cecchetti, Giordano;Agosta, Federica;Cividini, Camilla;Santangelo, Roberto;Filippi, Massimo
2021-01-01
Abstract
We evaluated the value of resting-state EEG source biomarkers to characterize mild cognitive impairment (MCI) subjects with an Alzheimer's disease (AD)-like cerebrospinal fluid (CSF) profile and to track neurodegeneration throughout the AD continuum. We further applied a resting-state functional MRI (fMRI)-driven model of source reconstruction and tested its advantage in terms of AD diagnostic accuracy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
